Before a standing-room only courtroom, a New York federal judge heard arguments Tuesday in a lawsuit questioning the patentability of human genes. The dispute centers on whether genes, once separated from the lengthy DNA sequence, are sufficiently "new and useful" to be deemed patentable under federal patent law. Multiple amicus briefs were filed on behalf of both sides of the case, which has become a lightning rod for the issue of genetic patenting.
February 03, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A federal judge in Manhattan heard arguments Tuesday in a lawsuit questioning the patentability of human genes.
The case, Association for Molecular Pathology v. U.S. Patent and Trademark Office, 09-civ-4515, centers on whether genes, once separated from the lengthy DNA sequence, are sufficiently “new and useful” to be deemed patentable under federal patent law.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
